Jasmina Aganovic ’09 founded Future Society, a brand that uses sequenced DNA from extinct flowers to create new scents, reports Celia Shatzman for Forbes. “[With] plants that are from another time, never before have we been able to time travel through smell,” says Aganovic. “But now we can do that, thanks specifically to DNA sequencing. It’s an example of where we're starting off with this concept of limitless nature. It isn't just about stories; it's also about performance.”
Xiangkun (Elvis) Cao, a Schmidt Science Fellow in MIT’s Department of Chemical Engineering, writes for Times Higher Education about the need to eliminate barriers between different academic disciplines. “More work needs to be done to support interdisciplinary researchers more generally,” writes Cao. “The lack of funding, incentives and community support holds back the scientific breakthroughs they could otherwise be making.”
7 News spotlights how MIT researchers have developed a new implantable device that could provide diabetes patients with insulin without using injections. “What we’ve been able to show is that with a minimally invasive implant that is sitting just under the skin, we’ve actually been able to sort of achieve a diabetic reversal,” explains Research Scientist Siddharth Krishnan.
Gizmodo reporter Ed Cara writes that MIT researchers have developed a new implantable device that can produce its own supply of insulin for up to a month. The team envisions that the device could “eventually be used for other medical conditions dependent on a regular supply of externally produced proteins, such as certain forms of anemia treated with erythropoietin,” writes Cara.
MIT researchers have developed a new implant that in the future could be used to deliver insulin to patients for up to a month, potentially enabling patients to control diabetes without injections, reports Tony Ho Tran for the Daily Beast. In the future, the researchers hope to “develop a device for humans that would be roughly the size of a stick of gum,” writes Tran. “The implant could also be used to deliver things like drugs or proteins to help treat other diseases in humans as well.”
Sean Hunt MS ’13 PhD ’16 co-founded Solugen, a startup working to develop industrial chemicals with environmentally friendly ingredients, reports David H. Freedman for Newsweek. “The company's goals over the next seven years are to reduce the carbon emissions released by industry into the environment by an amount equivalent to eliminating 2 million cars, and to make enough bioplastic to get rid of 5 billion non-degradable plastic bottles,” writes Freedman.
Researchers at MIT have developed a mobile vaccine printer capable of printing a vaccine onto a patch of microneedles that can be absorbed into the skin without injection, reports Sandra Tsing for NPR. “These printed vaccines could be used in areas that are unable to refrigerate traditional vaccines,” explains Tsing.
Institute Prof. Bob Langer speaks with Curiosity podcast hosts Immad Akhynd and Raj Suri about his work in the field of biotechnology, delving into how he has co-founded 40 companies. “I wanted to get out and do some good in the world,” says Langer. “That's where patents come in and that's where companies come in. And I think the challenge of the company is very different because you have what I call a platform technology.”
MIT has been selected as the world’s best university in the 2024 QS World University Rankings, reports Cecilia Rodriguez for Forbes. MIT has secured “the top position for the 12th consecutive year,” writes Rodriguez.
MIT scientists have found that the “motions of undulating animals and the states of quantum objects can be described using strikingly similar equations,” writes Karmela Padavic-Callaghan for New Scientist. The similarity “allowed the team to use mathematical tools previously developed by quantum physicists to analyze the animals,” notes Padavic-Callaghan. “For instance, the team quantified how differently a snake-like robot and a C. elegans move and created a diagram that placed them on a spectrum of other undulating creatures.”
Principal Research Scientist Ana Jaklenec speaks with CBC host Bob McDonald about her work developing a mobile vaccine printer. The device “can be very important in certain scenarios when you’re trying to bring the ability to vaccinate in areas that might not have the right infrastructure to make vaccines or even to administer vaccines,” says Jaklenec, “so I think the portability is key here.”
Alum Sophie Bai, founded B.A.I Biosciences and through her research has created Pavise, a skincare line focusing on sun care and aging, reports Celia Shatzman for Forbes. “I believe skincare starts with sun care, because 90% of skin problems are caused by UVA,” says Bai.
MIT has ranked first in 11 different academic fields in the latest QS World University Rankings, reports Michael T. Nietzel for Forbes.
WCVB spotlights postdoctoral associate Matt McDonald and his efforts to prepare for the 2023 Boston Marathon. McDonald, who finished fourth in the American pack at last year’s marathon and first among New Englanders, says “the crowds are unbelievable. And knowing that you’ve done it at that point, makes it just incredibly emotional.”
MIT researchers are developing targeted drug delivery through the use of nanoparticles to aid in cancer treatment, reports Simone Migliori for Boston Magazine. “Designed to circulate through the bloodstream, these small but mighty travelers [nanoparticles] can deliver a chemotherapy drug directly to a target cancer cell without disturbing any healthy cells along the way,” writes Migliori. “In doing so, patients may be able to avoid some of the worst side effects of chemotherapy drugs while still effectively treating their cancer.”